SMARTFINANCIAL INC. (SMBK)
SmartFinancial Announces Results for the First Quarter 2026
PERFECT CORP. (PERF)
Perfect Announces Appointment of Financial Advisor and Legal Counsel to the Special Committee
INNVENTURE, INC. (INV)
Accelsius Announces General Availability of NeuCool® IR150 and Launches NeuCool HyperStart Program at Data Center World 2026
STANLEY BLACK & DECKER, INC. (SWK)
Stanley Black & Decker Does Not Expect Recent Section 232 Tariff Changes To Impact 2026 Guidance Materially
INGLES MARKETS INC (IMKTA)
Ingles Markets Issues Open Letter to Shareholders
AECOM (ACM)
AECOM announces planned dates for second quarter fiscal 2026 earnings results and conference call
ANI PHARMACEUTICALS INC (ANIP)
ANI Pharmaceuticals Announces the FDA Approval and Launch of Pimozide Tablets with 180 Day CGT Exclusivity
PHARVARIS N.V. (PHVS)
Evidence Supporting Combined Use of Deucrictibant IR with Deucrictibant XR Presented at CIIC Spring 2026 Conference
BLACKSTONE SECURED LENDING FUND (BXSL)
Blackstone Secured Lending Announces First-Quarter 2026 Earnings Release and Conference Call
Merck & Company Inc (MRK)
FDA Grants Priority Review for KEYTRUDA®(pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), Each with Padcev® (enfortumab vedotin-ejfv), for Cisplatin-Eligible Patients with Muscle-Invasive Bladder Cancer